Should Value Investors Buy Bristol-Myers Squibb (BMY) Stock?HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Should Value Investors Buy Bristol-Myers Squibb (BMY) Stock?Zacks Equity ResearchZacksJanuary 3, 2020ReblogShareTweetShareHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.One company value investors might notice is Bristol-Myers Squibb (BMY). BMY is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. The stock is trading with P/E ratio of 14.36 right now. For comparison, its industry sports an average P/E of 16.43. BMY's Forward P/E has been as high as 14.36 and as low as 9.22, with a median of 10.69, all within the past year.BMY is also sporting a PEG ratio of 1.46. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. BMY's PEG compares to its industry's average PEG of 2.13. Within the past year, BMY's PEG has been as high as 2.48 and as low as 1.04, with a median of 2.01.Another valuation metric that we should highlight is BMY's P/B ratio of 5.89. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. BMY's current P/B looks attractive when compared to its industry's average P/B of 6.84. BMY's P/B has been as high as 6.22 and as low as 4.33, with a median of 5.05, over the past year.These are just a handful of the figures considered in Bristol-Myers Squibb's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that BMY is an impressive value stock right now.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY) : Free Stock Analysis Report To read this article on Zacks.com click here.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextAre Investors Undervaluing Cardtronics (CATM) Right Now?ZacksIs Euronav NV (EURN) a Great Value Stock Right Now?ZacksIs Macy's (M) Stock Undervalued Right Now?ZacksIs Dynex Capital (DX) Stock Undervalued Right Now?ZacksShould Value Investors Buy PetroChina (PTR) Stock?ZacksRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoHere are 5 reasons the stock market is having its worst decline since 2008, and only one of them is the coronavirusMarketWatchMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video